This cross-scale atlas prioritizes microbial and anatomical targets and provides a translational foundation for mechanistic validation and non-invasive neurodegenerative risk markers.
Abstract
Oral microbial dysbiosis is linked to systemic inflammatory, vascular, and metabolic perturbations, but species-level relationships with human brain structure remain poorly defined. Using two-sample Mendelian randomization, we mapped 438 of 439 oral species with genome-wide association study instruments to 1325 adult brain imaging-derived phenotypes. In total, 87 associations involving 51 taxa and 79 traits passed Benjamini–Hochberg correction across taxa within each imaging-derived phenotype. The childhood and metabolomic screens identified 196 nominal taxon–volume associations and 1118 candidate metabolite-linked paths, respectively, as exploratory findings. Spatial and single-nucleus transcriptomics localized candidate regional and cell-associated variation in brain-structure gene programs. In total, 35 taxa showed nominal genetic associations with Alzheimer’s disease. Integration with full-length oral 16S ribosomal ribonucleic acid gene sequencing from a 51-participant case–control cohort prioritized Selenomonas infelix, Capnocytophaga granulosa, and Dialister pneumosintes. In a secondary exploratory analysis, the three-taxon salivary model incorporating educational attainment yielded a leave-one-out cross-validated area under the receiver operating characteristic curve of 0.843. This post-selection estimate is subject to optimism, and the model remains a proof of concept requiring independent external validation. This cross-scale atlas prioritizes microbial and anatomical targets and provides a translational foundation for mechanistic validation and non-invasive neurodegenerative risk markers.
Background: Cellular heterogeneity limits causal inference in complex diseases. We applied an established cell-type-stratified Mendelian randomization (csMR) framework, originally developed by Hao et al. (2024), to investigate whether lipid phenotypes affect kidney disease through distinct brain cell populations, exten...
Common brain disorders impose a substantial health burden, but localizing their genetic risk in the brain remains challenging1. Although genome-wide association studies have identified numerous loci associated with neuropsychiatric and neurodegenerative disorders, many of these loci lie in non-coding regions that influ...
S. Venkatesh, Roman Kosoy, Zhen-Yi Wu et al.· Nature· 6 citations
Background Alzheimer’s disease (AD) is the leading cause of dementia, with early diagnosis remaining constrained by the invasiveness and limited accessibility of current biomarkers. The gut–brain axis has emerged as a critical communication network linking intestinal homeostasis with central nervous system function, ye...
Jiao Chen, Xu-Hui Chen, Weiwei Yu et al.· Frontiers in Pharmacology· 0 citations
Leveraging multi-omics to better understand the molecular signatures and pathways underlying Alzheimer’s disease (AD) pathogenesis is critical for early diagnosis and disease modifying interventions. We performed peripheral blood transcriptome (N = 669) and epigenome microarray analyses (N = 553) on non-Hispanic white...
Brendan A. Mitchell, I. Hausle, Sarah Smith et al.· npj Dementia· 0 citations
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by demyelination disseminated in space and time. Here we performed a genome-wide association study (GWAS) using 688 MS cases and 205,199 controls from the Japanese population and identified significant associations in...
Rintaro Fujimoto, K. Ogawa, S. Namba et al.· Nature Genetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.